2 terminated, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
Follow AB-729: new trials by email Literature Review of AB-729 trials Research Report on AB-729
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection AB-729, Peg-IFNα-2a - Chronic Hepatitis b | Phase 2 | Completed | Arbutus Biopharma Corporation | 43 | 2021-10-29 | 2026-04-29 |
| A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection VBR, AB-729, SOC NrtI - Chronic Hepatitis B | Phase 2 | Terminated | Assembly Biosciences | 65 | 2021-05-07 | 2023-11-14 |
| A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection ATI-2173, Viread, AB-729 - Hepatitis B, Chronic, Hepatitis D | Phase 2 | Terminated | Antios Therapeutics, Inc | 40 | 2021-03-30 | 2022-11-18 |
Hepatitis B, Chronic (3) · Hepatitis B (2) · Hepatitis (1) · Hepatitis D (1)
Antios Therapeutics, Inc (1) · Arbutus Biopharma Corporation (1) · Assembly Biosciences (1)
Australia (2) · Moldova (2) · Ukraine (2) · Bulgaria (1) · Canada (1) · Hong Kong (1) · New Zealand (1) · South Korea (1) · Taiwan (1) · United States (1)